Emerging new therapies for the treatment of type 2 diabetes mellitus: glucagon-like peptide-1 receptor agonists. [electronic resource]
Producer: 20160119Description: 483-93 p. digitalISSN:- 1879-114X
- Adult
- Clinical Trials, Phase III as Topic
- Diabetes Mellitus, Type 2 -- blood
- Drug Administration Schedule
- Exenatide
- Glucagon-Like Peptide 1 -- analogs & derivatives
- Glucagon-Like Peptide-1 Receptor -- therapeutic use
- Glucagon-Like Peptides -- analogs & derivatives
- Glycated Hemoglobin -- analysis
- Humans
- Hypoglycemia -- drug therapy
- Hypoglycemic Agents -- therapeutic use
- Immunoglobulin Fc Fragments -- therapeutic use
- Liraglutide -- therapeutic use
- Middle Aged
- Peptides -- therapeutic use
- Randomized Controlled Trials as Topic
- Receptors, Glucagon -- agonists
- Recombinant Fusion Proteins -- therapeutic use
- Venoms -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.